Cargando…

Effects of high-absorption curcumin for the prevention of hypertensive heart disease: a double-blind, placebo-controlled, randomized clinical study

AIMS: Hypertension is a strong risk factor for heart failure with preserved ejection fraction. Curcumin has p300-specific histone acetyltransferase inhibitory activity, suppresses cardiomyocyte hypertrophy and fibrosis, and significantly reduces myocardial brain natriuretic peptide (BNP) expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Funamoto, Masafumi, Sunagawa, Yoichi, Katanasaka, Yasufumi, Kato, Toru, Funada, Junichi, Ajiro, Yoichi, Komiyama, Maki, Akao, Masaharu, Yasoda, Akihiro, Yamakage, Hajime, Satoh-Asahara, Noriko, Wada, Hiromichi, Ikeda, Yasumasa, Morimoto, Tatsuya, Hasegawa, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512148/ https://www.ncbi.nlm.nih.gov/pubmed/36172003 http://dx.doi.org/10.1093/ehjopen/oeac057

Ejemplares similares

Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild COPD
por: Funamoto, Masafumi, et al.
Publicado: (2016)

Effects of Highly Absorbable Curcumin in Patients with Impaired Glucose Tolerance and Non-Insulin-Dependent Diabetes Mellitus
por: Funamoto, Masafumi, et al.
Publicado: (2019)

Neutrophil/lymphocyte ratio is correlated with levels of inflammatory markers and is significantly reduced by smoking cessation
por: Komiyama, Maki, et al.
Publicado: (2021)

Serum Cystatin C, a Sensitive Marker of Renal Function and Cardiovascular Disease, Decreases After Smoking Cessation
por: Funamoto, Masafumi, et al.
Publicado: (2019)

Randomised Double-blind Placebo-Controlled Multicentre Trial for the Effects of Yokukansan in Smokers with Depressive Tendencies
por: Komiyama, Maki, et al.
Publicado: (2023)

Anti-inflammatory Action of Curcumin and Its Use in the Treatment of Lifestyle-related Diseases
por: Shimizu, Kana, et al.
Publicado: (2019)

Study protocol to determine the effects of highly absorbable oral curcumin on the indicators of cognitive functioning: a double-blind randomised controlled trial
por: Komiyama, Maki, et al.
Publicado: (2022)

Analysis of changes on adiponectin levels and abdominal obesity after smoking cessation
por: Komiyama, Maki, et al.
Publicado: (2018)

Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan (YiganSan), in smokers with depressive tendencies
por: Komiyama, Maki, et al.
Publicado: (2022)

Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial
por: Hata, Akiko, et al.
Publicado: (2022)

Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation
por: Komiyama, Maki, et al.
Publicado: (2016)

A Novel Curcumin Formulation, ASD-Cur, Suppressed the Development of Systolic Dysfunction After Myocardial Infarction in Rats
por: Takai, Hidemichi, et al.
Publicado: (2021)

Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
por: Funamoto, Masafumi, et al.
Publicado: (2022)

Short-term Changes in Self-rating Depression Scale Scores after Smoking Cessation in Neurotic Patients
por: Komiyama, Maki, et al.
Publicado: (2020)

Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation
por: Komiyama, Maki, et al.
Publicado: (2017)

Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats
por: Sunagawa, Yoichi, et al.
Publicado: (2021)

Histone Acetylation Domains Are Differentially Induced during Development of Heart Failure in Dahl Salt-Sensitive Rats
por: Funamoto, Masafumi, et al.
Publicado: (2021)

The Synthetic Curcumin Analogue GO-Y030 Effectively Suppresses the Development of Pressure Overload-induced Heart Failure in Mice
por: Shimizu, Kana, et al.
Publicado: (2020)

The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoprotein
por: Komiyama, Maki, et al.
Publicado: (2014)

6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
por: Kawase, Yuto, et al.
Publicado: (2023)

The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan
por: Komiyama, Maki, et al.
Publicado: (2018)

Ecklonia stolonifera Okamura Extract Suppresses Myocardial Infarction-Induced Left Ventricular Systolic Dysfunction by Inhibiting p300-HAT Activity
por: Katagiri, Takahiro, et al.
Publicado: (2022)

The Polyunsaturated Fatty Acids EPA and DHA Prevent Myocardial Infarction-induced Heart Failure by Inhibiting p300-HAT Activity in Rats
por: Sunagawa, Yoichi, et al.
Publicado: (2021)

Young Investigator Award: Compound A, a Ginger Extract, Significantly Reduces Pressure Overload-induced Systolic Heart Failure in Mice
por: Kawase, Yuto, et al.
Publicado: (2021)

Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2020)

Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study
por: Wada, Hiromichi, et al.
Publicado: (2020)

Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED‐J Study
por: Wada, Hiromichi, et al.
Publicado: (2022)

Association between monocyte chemoattractant protein-1 and blood pressure in smokers
por: Komiyama, Maki, et al.
Publicado: (2017)

The Selective Serotonin 2A Receptor Antagonist Sarpogrelate Prevents Cardiac Hypertrophy and Systolic Dysfunction via Inhibition of the ERK1/2–GATA4 Signaling Pathway
por: Shimizu, Kana, et al.
Publicado: (2021)

Analysis of Factors That Determine Weight Gain during Smoking Cessation Therapy
por: Komiyama, Maki, et al.
Publicado: (2013)

Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response
por: Shimizu, Satoshi, et al.
Publicado: (2022)

BOT-5 Chrysanthemum morifolium extract improves doxorubicin-induced cardiomyopathy by suppressing apoptosis in mouse heart
por: Ono, Masaya, et al.
Publicado: (2021)

Chrysanthemum morifolium Extract Prevents the Development of Doxorubicin-induced Heart Failure
por: Ono, Masaya, et al.
Publicado: (2021)

The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
por: Tojima, Mikuto, et al.
Publicado: (2021)

VEGF‐C and Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2018)

Discovery of Novel Small Molecules for Heart Failure Therapy Using Cultured Cardiomyocyte by High Throughput Screening Assay
por: Shimizu, Satoshi, et al.
Publicado: (2021)

ANGPTL4 Expression Is Increased in Epicardial Adipose Tissue of Patients with Coronary Artery Disease
por: Katanasaka, Yasufumi, et al.
Publicado: (2022)

Chrysanthemum morifolium Extract Ameliorates Doxorubicin-Induced Cardiotoxicity by Decreasing Apoptosis
por: Ono, Masaya, et al.
Publicado: (2022)

CBMS-3 SEARCH FOR COMPOUNDS WITH ANTI-TUMOUR EFFECTS AGAINST GLIOBLASTOMA
por: Iwashimizu, Sonoka, et al.
Publicado: (2022)

TB-3 A GINGER EXTRACT COMPOUND A REVEALED ANTITUMOR ACTIVITY AGAINST GLIOMA
por: Inai, Kyoko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n2g80pso6uijot24sqq7n3jfa0